webinar
When an entire country is a cohort - Unique biobanks supporting personalized medicine
Join our webinar 28 April 2021 to learn more about the Danish nation-wide, comprehensive bio- and databanks with samples across generations and a strong methodology within the development of gene analysis and biomarkers (genomics and proteomics).
NB! We have changed our technical platform, so please use the link from the e-mail that you will receive 30 minutes before start - or click here to access the webinar. Do NOT use the link in the calendar invitation.
Denmark excels with its bio- and databanks
Biobanks are an important compound of personalized medicine and are central when accelerating the discovery and development of new drugs. Besides, biobanks play a key role in identification of new biomarkers.
This webinar will present three central institutions in the Danish research landscape within personalized medicine. All presentations will focus on concrete services and opportunities for collaboration and demonstrate how industry partners can benefit from collaborating with the Danish research community.
First, the Danish National Biobank, which main purpose is to give scientists from Denmark and abroad easy access to information from more than 25 million biological samples.
Second, the Nationwide Bio- and Genome Bank Denmark, which is a virtual national biobank with samples within e.g. cancer, rheumatology, diabetes, blood and Covid-19 that are available to national and international research projects.
Third, the Danish National Genome Center, which supports further development of more effective treatments, targeted the individual patient by the use of genome data and new technologies in Denmark.
Webinar program
- Presentation of The Danish National Biobank by Lasse Boding, head of the Coordinating Centre at the Danish National Biobank (DNB)
- The history and content of The Danish National Biobank.
- Examples illustrating the potential of the biobank for development and/or use of personalized medicine.
- The concrete services and opportunities for collaboration that The Danish National Biobank offers industry partners - how to proceed and the benefits of collaborating with Danish research community.
- Presentation of the Bio- and Genome Bank Denmark by professor Estrid Høgdall, director of the Nationwide Bio- and Genome Bank Denmark
- The content of Bio- and Genome Bank Denmark.
- Research examples illustrating the potential of the biobank (for development and/or use of personalised medicine) and company references.
- The services and opportunities for collaboration that the Bio- and Genome Bank Denmark offers industry partners - how to proceed and whom to contact?
- Presentation of the Danish National Genome Center (NGC) by Bettina Lundgren, CEO of Danish National Genome Center
- NGC, a corner stone in the Danish national strategy for personalized medicine.
- The vision of NGC – where is NGC now? What to expect over the coming years?
- The concrete services and opportunities for collaboration that NGC offers industry partners - how to proceed and whom to contact?
- Q&A with the Danish National Biobank, the Bio- and Genome Bank Denmark and the Danish National Genome Center.
Speaker info
Bettina Lundgren
Bettina Lundgren is CEO of Danish National Genome Center since the establishment of the center in 2019. She has a strong leadership profile, in-depth knowledge of the Danish healthcare system and extensive clinical experience from a range of clinical departments. Lundgren is a specialist in clinical microbiology and doctor of medical science (DMSc) from the University of Copenhagen. Lundgren has contributed as chair, vice chair and member of numerous committees, including several clinical health councils. Her experience also includes chairing implementation of several large regional and national healthcare IT-system and quality initiatives. Prior to her appointment at the Danish National Genome Center, Lundgren has been the centre director of more than 1,600 employees at Diagnostic Center Copenhagen University Hospital (Rigshospitalet). Lundgren’s career spans over 19 years of management experience in the Danish health care system and she has broad research experience from a number of positions in and outside Denmark, including the US National Institutes of Health (NIH), and she has contributed to more than 70 scientific publications.
Estrid Høgdall
Estrid Høgdall is Clinical professor in molecular pathology at University of Copenhagen and Head of Molecular Unit, Department of Pathology. She is director of the Nationwide Bio- and Genome Bank Denmark, which include the Danish CancerBiobank (DCB), the Danish RheumatologyBiobank (DRB), the Danish Diabetes Biobank (DDB), the Danish BlooddonorBiobank (DBB) and the Danish Civid19Biobank (D19B). Høgdall is responsible for the management, guideline description and programming of the database module. More nationwide biobanks are planned.
Career records of accomplishment are documented in the areas: Molecular pathology, biobanking and various tumor profiling expression analyses. Special focus and experience in biomarkers of colorectal and ovarian tumors. Høgdall is also attending Global Excellence through the Department of Gynaecology and Oncology at Rigshospitalet with MD Anderson, Professor R. Bast.
Publications in peer-reviewed journals: 353, Citations: 6.924, in press/submitted: 5 (H-Index: 50)
Lasse Boding
Lasse Boding is heading the Coordinating Centre at the Danish National Biobank (DNB). He holds an MSc in biochemistry and a PhD in biomedicine from the University of Copenhagen. During his Postdoc Lasse was involved in creating several research infrastructures and core facilities, which led him to the position as Coordinator at the DNB. Lasse is responsible for research activities and in securing smooth access to biological samples and corresponding data from the DNB. Other tasks involve ethical, legal and social issues (ELSI) as well as communication and outreach activities.
Moderator: Allan Skaarup Kristensen
Science & Innovation Attaché at Innovation Centre Denmark Silicon Valley (ICDK SV)/ San Francisco. ICDK SV builds bridges and facilitate partnerships between Danish and U.S. companies, research institutions and public stakeholders. Allan has previously worked for the Association of the Pharmaceutical Industry, the Society of Engineers and the Ministry of Higher Education and Science. He has 25 years of experience in the field of research policy and innovation and has in-depth knowledge about strategic planning of public research programs, research funding and foresight methods.
When an entire country is a cohort Webinar series on personalized medicine
The webinar is the second episode of an exciting 4-part webinar series on personalized medicine – from basic research to post-marketing activities.
Each episode will provide an overview of the Danish research infrastructure within a specific phase of the drug development process and an opportunity for virtual meetings with leading Danish researchers and physicians as well as key officials from public health data organizations, including biobanks, health data, clinical and technology research.
Attending the webinar series will provide a direct pathway to access the unique framework that Denmark offers for pharmaceutical companies for the research, development, and clinical use of personalized medicine.
The series will be free of charge and hosted by Invest in Denmark, a part of The Danish Ministry of Foreign Affairs, and the Danish Association of the Pharmaceutical Industry.
Watch more webinar episodes on personalized medicine here
get in touch Want to know more about the webinar or personalized medicine in Denmark?
Please contact our dedicated life science experts here:
Loading...